General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Abbvie(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Actavis(SIGNIFICANT), Amarin(SIGNIFICANT), Caladrius(SIGNIFICANT), Casana(SIGNIFICANT), CSL Behring(SIGNIFICANT), Cytokinetics(NONE), Imara(SIGNIFICANT), Eli Liily(SIGNIFICANT), Moderan(SIGNIFICANT), Reata(SIGNIFICANT), Relypsa(MODEST), Salamandra(SIGNIFICANT)

View Full Disclosure